Personalized sequencing and the future of medicine: discovery, diagnosis and defeat of disease

被引:51
|
作者
Esplin, Edward D. [1 ]
Oei, Ling [1 ]
Snyder, Michael P. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA
关键词
cancer genomics; disease discovery; electronic medical record; genomic medicine; individualized therapy; next-generation sequencing; personalized medicine; pharmacogenetics; pharmacogenomics; precision medicine; prevention; whole-exome sequencing; whole-genome sequencing; REVERSE-TRANSCRIPTASE; ENVIRONMENTAL-FACTORS; CLONAL EVOLUTION; CANCER GENOME; WHOLE-EXOME; MUTATIONS; ASSOCIATION; HYPERSENSITIVITY; HLA-B-ASTERISK-5701; RISK;
D O I
10.2217/pgs.14.117
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The potential for personalized sequencing to individually optimize medical treatment in diseases such as cancer and for pharmacogenomic application is just beginning to be realized, and the utility of sequencing healthy individuals for managing health is also being explored. The data produced requires additional advancements in interpretation of variants of unknown significance to maximize clinical benefit. Nevertheless, personalized sequencing, only recently applied to clinical medicine, has already been broadly applied to the discovery and study of disease. It is poised to enable the earlier and more accurate diagnosis of disease risk and occurrence, guide prevention and individualized intervention as well as facilitate monitoring of healthy and treated patients, and play a role in the prevention and recurrence of future disease. This article documents the advancing capacity of personalized sequencing, reviews its impact on disease-oriented scientific discovery and anticipates its role in the future of medicine.
引用
收藏
页码:1771 / 1790
页数:20
相关论文
共 50 条
  • [41] The future of telomere length in personalized medicine
    Gorenjak, Vesna
    Akbar, Samina
    Stathopoulou, Maria G.
    Visvikis-Siest, Sophie
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 1628 - 1654
  • [42] Personalized medicine in oncology: the future is now
    Schilsky, Richard L.
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (05) : 363 - 366
  • [43] Personalized (laboratory) medicine: a bridge to the future
    Plebani, Mario
    Lippi, Giuseppe
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (04) : 703 - 706
  • [44] Systems biology: personalized medicine for the future?
    Chen, Rui
    Snyder, Michael
    CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (05) : 623 - 628
  • [45] The future of chemotherapy in the era of personalized medicine
    Dieci M.V.
    Guarneri V.
    Conte P.
    Current Breast Cancer Reports, 2013, 5 (1) : 57 - 68
  • [46] Theranostic nanoparticles for future personalized medicine
    Ryu, Ju Hee
    Lee, Sangmin
    Son, Sohee
    Kim, Sun Hwa
    Leary, James F.
    Choi, Kuiwon
    Kwon, Ick Chan
    JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 477 - 484
  • [47] Training the Future Leaders in Personalized Medicine
    Mason-Suares, Heather
    Sweetser, David A.
    Lindeman, Neal I.
    Morton, Cynthia C.
    JOURNAL OF PERSONALIZED MEDICINE, 2016, 6 (01): : 1 - 7
  • [48] High-throughput sequencing: a breakthrough in molecular diagnosis for precision medicine
    Dongare, Dipali Barku
    Nishad, Shaik Shireen
    Mastoli, Sakshi Y.
    Saraf, Shubhini A.
    Srivastava, Nidhi
    Dey, Abhishek
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)
  • [49] Future of Medicine: Models in Predictive Diagnostics and Personalized Medicine
    Regierer, Babette
    Zazzu, Valeria
    Sudbrak, Ralf
    Kuehn, Alexander
    Lehrach, Hans
    MOLECULAR DIAGNOSTICS, 2013, 133 : 15 - 33
  • [50] Personalized cancer medicine and the future of pathology
    H. Moch
    P. R. Blank
    M. Dietel
    G. Elmberger
    K. M. Kerr
    J. Palacios
    F. Penault-Llorca
    G. Rossi
    T. D. Szucs
    Virchows Archiv, 2012, 460 : 3 - 8